rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11-12
|
pubmed:dateCreated |
2004-12-20
|
pubmed:abstractText |
Ciprofloxacin is effective in perianal Crohn's disease but after treatment discontinuation symptoms reoccur. Infliximab is effective but requires maintenance therapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0269-2813
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1329-36
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15606395-Adolescent,
pubmed-meshheading:15606395-Adult,
pubmed-meshheading:15606395-Anti-Infective Agents,
pubmed-meshheading:15606395-Antibodies, Monoclonal,
pubmed-meshheading:15606395-Ciprofloxacin,
pubmed-meshheading:15606395-Crohn Disease,
pubmed-meshheading:15606395-Double-Blind Method,
pubmed-meshheading:15606395-Drug Therapy, Combination,
pubmed-meshheading:15606395-Endosonography,
pubmed-meshheading:15606395-Female,
pubmed-meshheading:15606395-Follow-Up Studies,
pubmed-meshheading:15606395-Gastrointestinal Agents,
pubmed-meshheading:15606395-Humans,
pubmed-meshheading:15606395-Male,
pubmed-meshheading:15606395-Middle Aged,
pubmed-meshheading:15606395-Rectal Fistula,
pubmed-meshheading:15606395-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study.
|
pubmed:affiliation |
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands. rlwest1@hotmail.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|